Review
Accepted on 22 Jan 2025
Cell-Free DNA: A Metabolic Byproduct with Diagnostic and Prognostic Potential in Rheumatic Disorders
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537934
Volumes
25,139 Publications
Volume 16 - 2025
Original Research
Accepted on 22 Jan 2025
Typical and Atypical Metabolic Characteristics of Three Iridaceae Isoflavone Components: In Vitro and In Silico Studies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522857
Review
Accepted on 22 Jan 2025
New Strategies to Enhance the Efficiency and Precision of Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1550158
Original Research
Accepted on 22 Jan 2025
Unveiling the effects of Rosa canina oligosaccharide liposome on neuropathic pain and motor dysfunction following spinal cord injury in rats: Relevance to its antioxidative effects
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533025
Original Research
Accepted on 22 Jan 2025
Disproportionality Analysis of Upadacitinib-Related Adverse Events in Inflammatory Bowel Disease Using the FDA Adverse Event Reporting System Adverse Events of Upadacitinib in Inflammatory Bowel Disease: Insights from the FDA Adverse Event Reporting System Database
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1436183
Editorial
Accepted on 22 Jan 2025
Editorial on the Research Topic World No-Tobacco Day: An Ethnopharmacological Perspective
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1538085
Correction
Accepted on 22 Jan 2025
Corrigendum: Adverse Drug Events (ADEs) Risk Signal Mining Related to Eculizumab Based on the FARES Database
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558930
Review
Accepted on 22 Jan 2025
Luteolin: Exploring Its Therapeutic Potential and Molecular Mechanisms in Pulmonary Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1535555
Systematic Review
Accepted on 22 Jan 2025
Add-on Effect of Total Glucosides of Paeony on Conventional Therapies for Psoriasis: A Systematic Review and Meta-analysis of Randomized Controlled Trial
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527288
Original Research
Accepted on 22 Jan 2025
Structural analysis and treatment of acute liver injury of polysaccharides from the Radix Actinidiae Chinensis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544302
Original Research
Published on 22 Jan 2025
Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1474856
Original Research
Published on 22 Jan 2025
Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533571
Original Research
Published on 22 Jan 2025
Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529525
Volume 15 - 2024
Original Research
Published on 22 Jan 2025
Better understanding the phenotypic effects of drugs through shared targets in genetic disease networks
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1470931
Original Research
Published on 22 Jan 2025
Pirfenidone regulates seizures through the HMGB1/TLR4 axis to improve cognitive functions and modulate oxidative stress and neurotransmitters in PTZ-induced kindling in mice
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1528032
- 174 views
Mini Review
Published on 22 Jan 2025
Brief summary of the regulatory frameworks of regenerative medicine therapies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486812